AN2 Therapeutics, Inc. (ANTX)

CIK 1880438 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for AN2 Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 13, 202640001193125-26-420643
Oct 13, 202640001193125-26-420639
Oct 13, 202640001193125-26-420641
Sep 16, 202640001193125-26-393274
Sep 14, 2026S-80001880438-26-000002
Sep 11, 202640001193125-26-389545
Sep 8, 202640001193125-26-385511
Sep 4, 202640001193125-26-383697
Sep 2, 202640001193125-26-380595
Aug 27, 202630001193125-26-370943
Aug 19, 202640001193125-26-357225
Aug 17, 20261440001972481-26-000263
Aug 14, 202640001193125-26-351801
Aug 11, 20268-K0001193125-26-344549
Aug 11, 202610-Q0001193125-26-344569
Jul 10, 202640001193125-26-301165
Jul 10, 202640001193125-26-301092
Jul 10, 202640001193125-26-301166
Jul 10, 202640001193125-26-301167
Jun 9, 20268-K0001193125-26-262264
Jun 4, 20268-K0001193125-26-257430
Jun 2, 202640001193125-26-253622
May 15, 2026SCHEDULE 13G/A0002073679-26-000066
May 11, 20268-K0001193125-26-216752
May 11, 202610-Q0001193125-26-216755